The American Society of Addiction Medicine (ASAM) officially released its National Practice Guidelines for the Use of Medications in the Treatment of Addiction Involving Opioid Use and related products, ScienceDaily reports. The new guidelines should aid treatment programs in providing more effective therapies.
"Suboptimal treatment has likely contributed to expansion of the epidemic as well as concerns for unethical practices," writes Drs. Kyle Kampman of the University of Pennsylvania School of Medicine and Margaret Jarvis of Marworth Alcohol and Chemical Dependency Treatment Center.
"At the same time, access to competent treatment is profoundly restricted because few physicians are willing and able to provide it." The skill and time needed for effective use of medications for opioid use disorders "are not generally available to primary care doctors."
The guidelines include:
- Alter Prescribing Patterns for Pain Medication
- Expand Access to Naloxone
- Expand and Standardizing Medication-Assisted Treatment (MAT)
The new evidence-based recommendations are published in the Journal of Addiction Medicine.